Signify Health, Inc.
SGFY
SGFY was delisted on the 28th of March, 2023.
99 hedge funds and large institutions have $5.05B invested in Signify Health, Inc. in 2021 Q1 according to their latest regulatory filings, with 99 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
246% more call options, than puts
Call options by funds: $1.53M | Put options by funds: $441K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMVA
New Mountain Vantage Advisers
New York
|
+$4.32B |
| 2 |
BCVI
Bain Capital Venture Investors
Boston,
Massachusetts
|
+$207M |
| 3 |
FAM
Fred Alger Management
New York
|
+$112M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$61.4M |
Top Sellers
SGFY Hedge Fund Activity: Q1 2021 in Review
99 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Signify Health, Inc. (SGFY) for Q1 2021, worth a combined $5.05B.
Buyers outnumbered sellers: 99 funds opened new SGFY positions and 0 closed out — a net gain of 99 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was New Mountain Vantage Advisers, opening a new position worth an estimated $4.32B.
- 99 institutional investors held Signify Health, Inc. (SGFY) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $5.05B of Signify Health, Inc. stock for Q1 2021.
- 99 funds opened new Signify Health, Inc. positions in Q1 2021 and 0 closed out, a net change of +99 holders.
- The largest Signify Health, Inc. buyer in Q1 2021 was New Mountain Vantage Advisers, an estimated $4.32B added.
Based on aggregated 13F filings for Q1 2021.